{
  "$schema": "https://github.com/Open-Systems-Pharmacology/QualificationPlan/releases/download/v2.1/OSP_Qualification_Plan_Schema.json",
  "Projects": [
    {
      "Id": "Tizanidine",
      "Path": "https://github.com/Open-Systems-Pharmacology/Tizanidine-Model/blob/main/Tizanidine-Model.json"
    },
    {
      "Id": "Ethinylestradiol",
      "Path": "https://github.com/Open-Systems-Pharmacology/Ethinylestradiol-Model/blob/main/Ethinylestradiol-Model.json"
    },
    {
      "Id": "Fluvoxamine",
      "Path": "https://github.com/Open-Systems-Pharmacology/Fluvoxamine-Model/blob/cyp1a2_cyp2C19_DDI/Fluvoxamine-Model.json"
    },
    {
      "Id": "Mexiletine",
      "Path": "https://github.com/Open-Systems-Pharmacology/Mexiletine-Model/blob/main/Mexiletine-Model.json"
    },

    {
      "Id": "Tizanidine-Ethinylestradiol-DDI",
      "Path": "https://github.com/Open-Systems-Pharmacology/Ethinylestradiol-Tizanidine-DDI/blob/main/Ethinylestradiol-Tizanidine-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Tizanidine",
          "Project": "Tizanidine"
        },
        {
          "Type": "Compound",
          "Name": "Ethinylestradiol",
          "Project": "Ethinylestradiol"
        },
        {
          "Type": "Formulation",
          "Name": "Ethinylestradiol tablet",
          "Project": "Ethinylestradiol"
        },
        {
          "Type": "Formulation",
          "Name": "Tizanidine tablet fasted",
          "Project": "Tizanidine"
        }
      ],
      "SimulationParameters": [
      ]
    },
    {
      "Id": "Caffeine-Fluvoxamine-DDI",
      "Path": "https://github.com/esqLABS/Fluvoxamine-Caffeine-DDI/blob/alternative-fluvoxamine-model/Fluvoxamine-Caffeine-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Fluvoxamine",
          "Project": "Fluvoxamine"
        },
        {
          "Type": "Formulation",
          "Name": "Fluvoxamine tablet",
          "Project": "Fluvoxamine"
        }
      ],
      "SimulationParameters": [
      ]
    },
    {
      "Id": "Tizanidine-Fluvoxamine-DDI",
      "Path": "https://github.com/Open-Systems-Pharmacology/Fluvoxamine-Tizanidine-DDI/blob/main/Fluvoxamine-Tizanidine-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Fluvoxamine",
          "Project": "Fluvoxamine"
        },
        {
          "Type": "Compound",
          "Name": "Tizanidine",
          "Project": "Tizanidine"
        },
        {
          "Type": "Formulation",
          "Name": "Fluvoxamine tablet",
          "Project": "Fluvoxamine"
        },
        {
          "Type": "Formulation",
          "Name": "Tizanidine tablet fasted",
          "Project": "Tizanidine"
        }
      ],
      "SimulationParameters": [
      ]
    },
    {
      "Id": "Caffeine-Mexiletine-DDI",
      "Path": "https://github.com/Open-Systems-Pharmacology/Mexiletine-Caffeine-DDI/blob/main/Mexiletine-Caffeine-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Mexiletine",
          "Project": "Mexiletine"
        },
        {
          "Type": "Formulation",
          "Name": "Mexiletine tablet",
          "Project": "Mexiletine"
        }
      ],
      "SimulationParameters": [
      ]
    },
    {
      "Id": "Tizanidine-Mexiletine-DDI",
      "Path": "https://github.com/Open-Systems-Pharmacology/Mexiletine-Tizanidine-DDI/blob/main/Mexiletine-Tizanidine-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Mexiletine",
          "Project": "Mexiletine"
        },
        {
          "Type": "Compound",
          "Name": "Tizanidine",
          "Project": "Tizanidine"
        },
        {
          "Type": "Formulation",
          "Name": "Mexiletine tablet",
          "Project": "Mexiletine"
        },
        {
          "Type": "Formulation",
          "Name": "Tizanidine tablet fasted",
          "Project": "Tizanidine"
        },
        {
          "Type": "Formulation",
          "Name": "Tizanidine tablet fed",
          "Project": "Tizanidine"
        }
      ],
      "SimulationParameters": [
      ]
    },
    {
      "Id": "Mexiletine-Fluvoxamine-DDI",
      "Path": "https://github.com/Open-Systems-Pharmacology/Fluvoxamine-Mexiletine-DDI/blob/main/Fluvoxamine-Mexiletine-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Mexiletine",
          "Project": "Mexiletine"
        },
        {
          "Type": "Compound",
          "Name": "Fluvoxamine",
          "Project": "Fluvoxamine"
        },
        {
          "Type": "Formulation",
          "Name": "Mexiletine tablet",
          "Project": "Mexiletine"
        },
        {
          "Type": "Formulation",
          "Name": "Fluvoxamine tablet",
          "Project": "Fluvoxamine"
        }
      ],
      "SimulationParameters": [
      ]
    },
    {
      "Id": "Caffeine-Ethinylestradiol-DDI",
      "Path": "https://github.com/Open-Systems-Pharmacology/Ethinylestradiol-Caffeine-DDI/blob/main/Ethinylestradiol-Caffeine-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Ethinylestradiol",
          "Project": "Ethinylestradiol"
        },
        {
          "Type": "Formulation",
          "Name": "Ethinylestradiol tablet",
          "Project": "Ethinylestradiol"
        }
      ],
      "SimulationParameters": [
      ]
    }
  ],
  "ObservedDataSets": [
    {
      "Id": "DDI Ratios",
      "Path": "https://github.com/esqLABS/Database-for-observed-data/blob/master/DDI.csv",
      "Type": "DDIRatio"
    }
  ],
  "Plots": {
    "AxesSettings": {
      "GOFMergedPlotsPredictedVsObserved": [
        {
          "Type": "X",
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml",
          "GridLines": false,
          "Scaling": "Log"
        },
        {
          "Type": "Y",
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml",
          "GridLines": false,
          "Scaling": "Log"
        }
      ],
      "GOFMergedPlotsResidualsOverTime": [
        {
          "Type": "X",
          "Dimension": "Time",
          "Unit": "h",
          "GridLines": false,
          "Scaling": "Linear"
        },
        {
          "Type": "Y",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Linear"
        }
      ],
      "ComparisonTimeProfile": [
        {
          "Type": "X",
          "Dimension": "Time",
          "Unit": "h",
          "GridLines": false,
          "Scaling": "Linear"
        },
        {
          "Type": "Y",
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml",
          "GridLines": false,
          "Scaling": "Log"
        }
      ],
      "DDIRatioPlotsPredictedVsObserved": [
        {
          "Type": "X",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        },
        {
          "Type": "Y",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        }
      ],
      "DDIRatioPlotsResidualsVsObserved": [
        {
          "Type": "X",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        },
        {
          "Type": "Y",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        }
      ],
      "PKRatioPlots": [
        {
          "Type": "X",
          "Dimension": "Age",
          "Unit": "year(s)",
          "GridLines": false,
          "Scaling": "Linear"
        },
        {
          "Type": "Y",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        }
      ]
    },
    "PlotSettings": {
      "ChartWidth": 500,
      "ChartHeight": 400,
      "Fonts": {
        "AxisSize": 11,
        "LegendSize": 9,
        "OriginSize": 9,
        "FontFamilyName": "Arial",
        "WatermarkSize": 40
      }
    },
    "AllPlots": [],
    "GOFMergedPlots": [],
    "ComparisonTimeProfilePlots": [
      {
        "SectionId": 301,
        "Title": "Granfors 2005 (Tizanidine 4 mg po)",
        "SimulationDuration": 492,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Tizanidine-Ethinylestradiol-DDI",
            "Simulation": "Tizanidine 4mg po",
            "Output": "Organism|PeripheralVenousBlood|Tizanidine|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Tizanidine.Granfors2005.4.po.without EE",
            "StartTime": 480,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Ethinylestradiol)",
            "Symbol": "Circle"
          },
          {
            "Project": "Tizanidine-Ethinylestradiol-DDI",
            "Simulation": "Tizanidine 4mg po Ethinylestradiol 20mg po",
            "Output": "Organism|PeripheralVenousBlood|Tizanidine|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Tizanidine.Granfors2005.4.po.with EE",
            "StartTime": 480,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Ethinylestradiol",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 302,
        "Title": "Jeppesen 1996 (Caffeine 200 mg po)",
        "SimulationDuration": 290,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Caffeine-Fluvoxamine-DDI",
            "Simulation": "Caffeine 200mg po",
            "Output": "Organism|PeripheralVenousBlood|Caffeine|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Jeppesen1996.Caffeine.200.po.day8.No_Fluvox",
            "StartTime": 168,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Fluvoxamine)",
            "Symbol": "Circle"
          },
          {
            "Project": "Caffeine-Fluvoxamine-DDI",
            "Simulation": "Caffeine 200mg po 400g Fluvox",
            "Output": "Organism|PeripheralVenousBlood|Caffeine|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Jeppesen1996.Caffeine.200.po.day8.With_Fluvox",
            "StartTime": 168,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Fluvoxamine",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 302,
        "Title": "Culm-Merdeck 2005 (Caffeine 250 mg po)",
        "SimulationDuration": 50,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Caffeine-Fluvoxamine-DDI",
            "Simulation": "Caffeine 250mg po",
            "Output": "Organism|PeripheralVenousBlood|Caffeine|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Culm-Merdeck2005.Caffeine.250.po.No_Fluvox",
            "StartTime": 25,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Fluvoxamine)",
            "Symbol": "Circle"
          },
          {
            "Project": "Caffeine-Fluvoxamine-DDI",
            "Simulation": "Caffeine 250mg 120mg predose po100mg Fluvox",
            "Output": "Organism|PeripheralVenousBlood|Caffeine|Plasma (Peripheral Venous Blood)",
            "ObservedData": "CulmMerdek2005_250mgSD_NA_NA_Caffeine_DDI",
            "StartTime": 25,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Fluvoxamine",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 303,
        "Title": "Granfors 2004 (Tizanidine 4 mg po)",
        "SimulationDuration": 98,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Tizanidine-Fluvoxamine-DDI",
            "Simulation": "Tizanidine 4mg po",
            "Output": "Organism|PeripheralVenousBlood|Tizanidine|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Granfors2004.Tizanidine.4mg.po.sd.Tab_fasted.control.DAY4",
            "StartTime": 73,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Fluvoxamine)",
            "Symbol": "Circle"
          },
          {
            "Project": "Tizanidine-Fluvoxamine-DDI",
            "Simulation": "Tizanidine 4mg po Fluvoxamine 100mg",
            "Output": "Organism|PeripheralVenousBlood|Tizanidine|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Granfors2004.Tizanidine.4mg.po.sd.Tab_fasted.withFluvoxamine_DAY4",
            "StartTime": 73,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Fluvoxamine",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 304,
        "Title": "Momo 2010 (Tizanidine 2 mg po)",
        "SimulationDuration": 30,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Tizanidine-Mexiletine-DDI",
            "Simulation": "Tizanidine 2mg po",
            "Output": "Organism|PeripheralVenousBlood|Tizanidine|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Momo2010.Tizanidine.m.2.po.control",
            "StartTime": 24,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Mexiletine)",
            "Symbol": "Circle"
          },
          {
            "Project": "Tizanidine-Mexiletine-DDI",
            "Simulation": "Tizanidine 2mg po Mexiletine 50mg",
            "Output": "Organism|PeripheralVenousBlood|Tizanidine|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Momo2010.Tizanidine.m.2.po.withMexiletine",
            "StartTime": 24,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Mexiletine",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 305,
        "Title": "Joeres 1987 (Caffeine 336 mg po)",
        "SimulationDuration": 25,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Caffeine-Mexiletine-DDI",
            "Simulation": "Caffeine 366mg po",
            "Output": "Organism|PeripheralVenousBlood|Caffeine|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Joeres1987.Caffeine.366.po",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Mexiletine)",
            "Symbol": "Circle"
          },
          {
            "Project": "Caffeine-Mexiletine-DDI",
            "Simulation": "Caffeine 366mg po Mexiletine 200mg",
            "Output": "Organism|PeripheralVenousBlood|Caffeine|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Joeres1987.Caffeine+Mexiletine.366.po",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Mexiletine",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 306,
        "Title": "Kusumoto 2001 (Mexiletine 166.62 mg po)",
        "SimulationDuration": 193,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Mexiletine-Fluvoxamine-DDI",
            "Simulation": "Mexiletine 166.62 mg po",
            "Output": "Organism|PeripheralVenousBlood|Mexiletine|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kusumoto2001.Mexiletine.m.166.62.po",
            "StartTime": 168,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Fluvoxamine)",
            "Symbol": "Circle"
          },
          {
            "Project": "Mexiletine-Fluvoxamine-DDI",
            "Simulation": "Mexiletine 166.62 mg po Fluvoxamine 50mg bid",
            "Output": "Organism|PeripheralVenousBlood|Mexiletine|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kusumoto2001.Mexiletine+Fluvoxamine.m.166.62.po",
            "StartTime": 168,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Fluvoxamine",
            "Symbol": "Square"
          }
        ]
      }

    ],
    "DDIRatioPlots": [
      {
        "SectionId": 2,
        "Title": "CYP1A2 DDI",
        "PKParameter": "AUC|CMAX",
        "PlotType": "predictedVsObserved|residualsVsObserved",
        "Artifacts": [
          "Plot",
          "GMFE",
          "Measure",
          "Table"
        ],
        "Groups": [
          {
            "Caption": "Tizanidine + Ethinylestradiol",
            "Color": "#FF0000",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Tizanidine|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 6050,
                "SimulationControl": {
                  "Project": "Tizanidine-Ethinylestradiol-DDI",
                  "Simulation": "Tizanidine 4mg po",
                  "StartTime": 480,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Tizanidine-Ethinylestradiol-DDI",
                  "Simulation": "Tizanidine 4mg po Ethinylestradiol 20mg po",
                  "StartTime": 480,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Caffeine + Fluvoxamine",
            "Color": "#008000",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Caffeine|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 6060,
                "SimulationControl": {
                  "Project": "Caffeine-Fluvoxamine-DDI",
                  "Simulation": "Caffeine 200mg po",
                  "StartTime": 168,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Caffeine-Fluvoxamine-DDI",
                  "Simulation": "Caffeine 200mg po 400g Fluvox",
                  "StartTime": 168,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Caffeine|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 6061,
                "SimulationControl": {
                  "Project": "Caffeine-Fluvoxamine-DDI",
                  "Simulation": "Caffeine 250mg po",
                  "StartTime": 25,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Caffeine-Fluvoxamine-DDI",
                  "Simulation": "Caffeine 250mg 120mg predose po100mg Fluvox",
                  "StartTime": 25,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Tizanidine + Fluvoxamine",
            "Color": "#0000FF",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Tizanidine|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 6070,
                "SimulationControl": {
                  "Project": "Tizanidine-Fluvoxamine-DDI",
                  "Simulation": "Tizanidine 4mg po",
                  "StartTime": 73,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Tizanidine-Fluvoxamine-DDI",
                  "Simulation": "Tizanidine 4mg po Fluvoxamine 100mg",
                  "StartTime": 73,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Caffeine + Mexiletine",
            "Color": "#00C0C0",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Caffeine|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 6080,
                "SimulationControl": {
                  "Project": "Caffeine-Mexiletine-DDI",
                  "Simulation": "Caffeine 366mg po",
                  "StartTime": 0,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Caffeine-Mexiletine-DDI",
                  "Simulation": "Caffeine 366mg po Mexiletine 200mg",
                  "StartTime": 0,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Tizanidine + Mexiletine",
            "Color": "#FF00FF",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Tizanidine|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 6090,
                "SimulationControl": {
                  "Project": "Tizanidine-Mexiletine-DDI",
                  "Simulation": "Tizanidine 2mg po",
                  "StartTime": 24,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Tizanidine-Mexiletine-DDI",
                  "Simulation": "Tizanidine 2mg po Mexiletine 50mg",
                  "StartTime": 24,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Mexiletine + Fluvoxamine",
            "Color": "#003300",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Mexiletine|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 6100,
                "SimulationControl": {
                  "Project": "Mexiletine-Fluvoxamine-DDI",
                  "Simulation": "Mexiletine 166.62 mg po",
                  "StartTime": 168,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Mexiletine-Fluvoxamine-DDI",
                  "Simulation": "Mexiletine 166.62 mg po Fluvoxamine 50mg bid",
                  "StartTime": 168,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Caffeine + Ethinylestradiol",
            "Color": "#b2182b",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Caffeine|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 6110,
                "SimulationControl": {
                  "Project": "Caffeine-Ethinylestradiol-DDI",
                  "Simulation": "Caffeine 200mg po",
                  "StartTime": 480,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Caffeine-Ethinylestradiol-DDI",
                  "Simulation": "Caffeine 200mg po Ethinylestradiol 0.03mg po",
                  "StartTime": 480,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              }
            ]
          }
        ]
      }
    ]
  },
  "Inputs": [],
  "Sections": [
    {
      "Id": 1,
      "Title": "1 Introduction",
      "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Empty.md",
      "Sections": [
        {
          "Id": 11,
          "Title": "1.1 Objective",
          "Content": "Content/Qualification_objective.md"
        },
        {
          "Id": 12,
          "Title": "1.2 CYP1A2 DDI Network",
          "Content": "Content/Qualification_DDI_network_description.md",
          "Sections": [
            {
              "Id": 1201,
              "Title": "Tizanidine - Ethinylestradiol DDI",
              "Content": "Content/Tizanidine-Ethinylestradiol-DDI.md"
            },
            {
              "Id": 1202,
              "Title": "Caffeine - Fluvoxamine DDI",
              "Content": "Content/Caffeine-Fluvoxamine-DDI.md"
            },
            {
              "Id": 1203,
              "Title": "Tizanidine - Fluvoxamine DDI",
              "Content": "Content/Tizanidine-Fluvoxamine-DDI.md"
            },
            {
              "Id": 1204,
              "Title": "Tizanidine - Mexiletine DDI",
              "Content": "Content/Tizanidine-Mexiletine-DDI.md"
            },
            {
              "Id": 1205,
              "Title": "Caffeine - Mexiletine DDI",
              "Content": "Content/Caffeine-Mexiletine-DDI.md"
            },
            {
              "Id": 1206,
              "Title": "Mexiletine - Fluvoxamine DDI",
              "Content": "Content/Mexiletine-Fluvoxamine-DDI.md"
            }
          ]
        }
      ]
    },
    {
      "Id": 2,
      "Title": "2 Qualification of Use Case CYP1A2-mediated DDI",
      "Content": "Content/Intro_evaluation_DDI_network.md"
    },
    {
      "Id": 3,
      "Title": "3 Concentration-Time Profiles",
      "Content": "Content/Intro_evaluation_CTprofiles.md",
      "Sections": [
        {
          "Id": 301,
          "Title": "3.1 Tizanidine - Ethinylestradiol DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Empty.md"
        },
        {
          "Id": 302,
          "Title": "3.2 Caffeine - Fluvoxamine DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Empty.md"
        },
        {
          "Id": 303,
          "Title": "3.3 Tizanidine - Fluvoxamine DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Empty.md"
        },
        {
          "Id": 304,
          "Title": "3.2 Tizanidine - Mexiletine DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Empty.md"
        },
        {
          "Id": 305,
          "Title": "3.4 Caffeine - Mexiletine DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Empty.md"
        },
        {
          "Id": 306,
          "Title": "3.5 Mexiletine - Fluvoxamine DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Empty.md"
        }
      ]
    },
    {
      "Id": 4,
      "Title": "4 Conclusion",
      "Content": "Content/Section4_Conclusion.md",
      "Sections": []
    },
    {
      "Id": 5,
      "Title": "5 References",
      "Content": "Content/References.md",
      "Sections": []
    },
    {
      "Id": 6,
      "Title": "6 Appendix",
      "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Empty.md",
      "Sections": [
        {
          "Id": 61,
          "Title": "6.1 Open Systems Pharmacology Suite (OSPS) Introduction",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/OSPS_Introduction.md"
        },
        {
          "Id": 62,
          "Title": "6.2 Mathematical Implementation of Drug-Drug Interactions",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Mathematical_Implementation_of_DDI.md"
        },
        {
          "Id": 63,
          "Title": "6.3 Automatic (re)-qualification workflow",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Qualification_Workflow.md"
        }
      ]
    },
    {
      "Id": 7,
      "Title": "7 Glossary",
      "Content": "Content/glossary.md"
  }
  ],
  "Intro": [
    {
      "Path": "Content/titlepage.md"
    }
  ]
}